ChEMBL
biological activities prediction for 1–5-bromofur-2-il-2-bromo-2-nitroethene
(G1) is a difficult task for cytokine immunotoxicity. The current
study presents experimental results for G1 interaction with mouse
Th1/Th2 and pro-inflammatory cytokines using a cytometry bead array
(CBA). In the in vitro test of CBA, the results show
no significant differences between the mean values of the Th1/Th2
cytokines for the samples treated with G1 with respect to the negative
control, but there are moderate differences for cytokine values between
different periods (24/48 h). The experiments show no significant differences
between the mean values of the pro-inflammatory cytokines for the
samples treated with G1, regarding the negative control, except for
the values of tumor necrosis factor (TNF) and Interleukin (IL6) between
the group treated with G1 and the negative control at 48 h. Differences
occur for these cytokines in the periods (24/48 h). The study confirmed
that the antimicrobial G1 did not alter the Th1/Th2 cytokines concentration in vitro in different periods, but it can alter TNF and
IL6. G1 promotes free radicals production and activates damage processes
in macrophages culture. In order to predict all ChEMBL activities
for drugs in other experimental conditions, a ChEMBL data set was
constructed using 25 biological activities, 1366 assays, 2 assay types,
4 assay organisms, 2 organisms, and 12 cytokine targets. Molecular
descriptors calculated with Rcpi and 15 machine learning methods were
used to find the best model able to predict if a drug could be active
or not against a specific cytokine, in specific experimental conditions.
The best model is based on 120 selected molecular descriptors and
a deep neural network with area under the curve of the receiver operating
characteristic of 0.904 and accuracy of 0.832. This model predicted
1384 G1 biological activities against cytokines in all ChEMBL data
set experimental conditions.